Section Arrow
RXST.NASDAQ
- RxSight
Quotes are at least 15-min delayed:2025/04/30 00:09 EDT
Last
 15.24
+0.68 (+4.67%)
Day High 
15.41 
Prev. Close
14.56 
1-M High
26.38 
Volume 
2.08M 
Bid
14.43
Ask
15.25
Day Low
14.4285 
Open
14.63 
1-M Low
13.5 
Market Cap 
591.43M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.52 
20-SMA 16.48 
50-SMA 22.75 
52-W High 66.54 
52-W Low 13.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.71/-0.40
Enterprise Value
602.75M
Balance Sheet
Book Value Per Share
6.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
139.93M
Operating Revenue Per Share
1.65
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/30 00:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.